Can I read BYL719: New PI3K Inhibitor for Osteosarcoma on EtoBox?

BYL719: New PI3K Inhibitor for Osteosarcoma by mohammad.azeemcu is a document available to read on EtoBox.

What is BYL719: New PI3K Inhibitor for Osteosarcoma about?

The study investigates BYL719, a novel PI3K inhibitor, for its therapeutic potential in treating osteosarcoma, both as a monotherapy and in combination with conventional chemotherapy. Results show that BYL719 effectively inhibits cell proliferation and migration in osteosarcoma cells, significantly reducing tumor progression and vascularization in murine models. The findings suggest that BYL719 could be a promising treatment option for osteosarcoma, particularly when combined with ifosfamide.

Author

mohammad.azeemcu

Language

EN